Skip to main content
. 2019 Apr 16;10:340. doi: 10.3389/fneur.2019.00340

Table 3.

Correlations among variables (N = 134).

PDSS-2 total PDSS-2 motor| PDSS-2 Night symptom PDSS-2 Disturbed sleep
Onset age −0.12 −0.20* −0.19* −0.06
Current age 0.06 −0.07 0.05 0.07
Disease duration 0.33** 0.27** 0.26** 0.25**
MMSE 0.05 0.01 −0.03 −0.07
UPDRS total 0.44** 0.38** 0.45** 0.40**
UPDRS Part I 0.17 0.15 0.17* 0.21*
UPDRS Part II 0.47** 0.43** 0.47** 0.42
UPDRS Part III 0.27** 0.23** 0.28** 0.21*
UPDRS Part IV 0.40** 0.40** 0.44** 0.43**
BDI 0.39** 0.25** 0.40** 0.47**
BAI 0.44** 0.39** 0.41** 0.34**
H&Y 0.38** 0.25** 0.22* 0.25**
PDQ-39 0.53** 0.41** 0.52** 0.47**
PDSS-2 0.69** 0.69** 0.68**
LEDD total 0.41** 0.31** 0.37** 0.38**
Dopamine agonist −0.01 −0.04 0.13 −0.04

PDSS-2, Parkinson Disease Sleep Scale-2; UPDRS, Unified Parkinson Disease Rating Scale; BDI, Beck Depression Inventory; BAI, Beck Anxiety Inventory; H&Y, Hoehn and Yahr scale; PDQ-39, 39-item Parkinson Disease Questionnaire; LEDD, Levodopa Equivalent Daily Dosage.

*

p < 0.05,

**

p < 0.01.